Leading biotech firms are integrating AI-driven workflows to accelerate drug discovery and bioprocessing. Ginkgo Bioworks, Inductive Bio, and Tangible Scientific announced a partnership to deliver AI-driven lab-in-the-loop compound design and experimental validation, streamlining drug development. Concurrently, Sanofi's digital transformation program showcased AI applications improving cellular image recognition, manufacturing efficiency, and formulation development. These advances highlight the growing role of AI and automation in enhancing precision, reducing costs, and compressing timelines across biotech.